Neoantigens Market Projected to Reach US$ 10,54,783.54 Thousand by 2028

According to The Insight Partners market research study titled "Neoantigens Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Treatment and Therapeutic Specialty," the market is expected to reach US$ 10,54,783.54 thousand by 2028 from US$ 2,71,428.57 thousand in 2023. It is estimated to grow at a CAGR of 31.2% from 2023 to 2028. The report highlights the trends prevalent in the market and the factors driving the market along with those that act as deterrents to its growth.

Download PDF Sample Copy at:
https://www.theinsightpartners.com/sample/TIPRE00021781/?utm_source=OpenPR&utm_medium=10376

Global Leaders:

Achilles Therapeutics plc; Advaxis, Inc.; Frame Cancer Therapeutics; Genocea; Gradalis, Inc.; Gritstone Oncology; Medigene AG; Ziopharm Oncology, Inc.; and Moderna, Inc. are among the prominent players operating in the neoantigens market. Following are the two identified key players in the market based on their product offering as well as R&D expenditures and developments. The companies have implemented several inorganic strategies to enhance the product development and commercialize their products in the market. For instance, in January 2021, Gradalis confirmed that results from the VITAL clinical trial were released in The Lancet Oncology, demonstrating that Vigil front-line maintenance use was well accepted and resulted in increased recurrence-free survival (RFS) and overall survival (OS) in patients with BRCA1/2 -wt advanced ovarian cancer.

Segments - By Treatment:

Based on treatment, the neoantigens market is segmented into combination therapy and mono therapy. In 2023, combination therapy is estimated to hold a larger share of the market, whereas the mono therapy segment is estimated to grow at a faster CAGR of 33.0%. Growth of the combination therapy segment is attributed to increasing numbers of clinical trials performed with other immunotherapies such as checkpoint inhibitors. Various collaborations are performed by the companies operating in this segment, which is likely to foster the market growth in coming years.

Have a Call with Our Analyst:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00021781/?utm_source=OpenPR&utm_medium=10376

Major Key Points of Neoantigens Market:

• Neoantigens Market Overview
• Neoantigens Market Competition
• Neoantigens Market, Revenue and Price Trend
• Neoantigens Market Analysis by Application
• Company Profiles and Key Figures in Neoantigens Market
• Market Dynamics
• Methodology and Data Source

Report Introduction, Overview, and In-depth industry analysis:

• 150+ Pages Research Report
• Includes List of table & figures
• Regional Analysis with Graphical Representation of Size, Share & Trends
• Provide Chapter-wise guidance on Request
• Facts and Factors research methodology
• Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis

Buy Report at:
https://www.theinsightpartners.com/buy/TIPRE00021781/?utm_source=OpenPR&utm_medium=10376

Contact us:

If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About The Insight Partners:

The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.

This release was published on openPR.